Oric Pharmaceuticals Inc. (ORIC) Social Stream



Oric Pharmaceuticals Inc. (ORIC): $8.77

0.05 (+0.57%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ORIC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#211 of 359

in industry

ORIC PHARMACEUTICALS INC (ORIC) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ORIC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 6 $52 $31 $39.333 $8.04 389.22%
2022-01-26 6 $52 $31 $38.166 $8.04 374.7%
2022-03-22 7 $33 $7 $18 $8.04 123.88%
2022-04-04 6 $33 $10 $19 $8.04 136.32%
2022-05-11 6 $17 $10 $13.666 $8.04 69.98%
2022-08-12 6 $17 $10 $14 $8.04 74.13%
2022-11-08 6 $15 $10 $12.5 $8.04 55.47%
2022-12-09 6 $16 $10 $13.666 $8.04 69.98%
2023-03-17 6 $16 $10 $13.75 $8.04 71.02%
2023-03-21 6 $15 $10 $13.5 $8.04 67.91%
2023-03-23 6 $16 $14 $15 $8.04 86.57%
2023-04-05 5 $16 $8 $13.833 $8.04 72.05%
2023-05-09 6 $16 $8 $13.833 $8.04 72.05%
2023-05-10 6 $15 $8 $13.5 $8.04 67.91%
2023-08-13 6 $15 $8 $13.333 $8.04 65.83%
2023-08-16 7 $27 $8 $15.142 $8.04 88.33%
2023-09-05 7 $27 $13 $15.857 $8.04 97.23%
2023-10-22 8 $27 $13 $15.625 $8.04 94.34%
2023-11-13 8 $27 $14 $16.625 $8.04 106.78%
2023-12-11 8 $27 $12 $16.375 $8.04 103.67%
2023-12-13 8 $27 $12 $16.25 $8.04 102.11%

The Trend in the Analyst Price Target


Over the past 37 months, ORIC's average price target has gone down $28.92.

Over the past 39 weeks, ORIC's average upside potential has been 141.27%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-17 6 16 10 13.750 4.56 201.54%
2023-03-23 5 16 10 14.166 5.20 172.42%
2023-05-10 6 15 8 13.500 5.14 162.65%
2023-10-26 8 27 14 16.625 6.48 156.56%
2023-11-13 8 27 14 16.625 6.13 171.21%

ORIC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 8 0 0 0 0 8

The Trend in the Broker Recommendations


ORIC's average broker recommendation rating improved by 0.33 over the prior 23 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how ORIC PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 2124.58% of that group.
  • In the context of all US stocks, ORIC PHARMACEUTICALS INC's average analyst price target is higher than 576.92% of them.
  • In terms of how ORIC PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1669.73% of that group.
  • ORIC has a greater number of analysts covering the stock than 1978.98% of stocks in the small market cap category.

In the Pharmaceutical Products industry, PLRX, CALT, and RNA are the three stocks most similar to ORIC PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for ORIC? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!